Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Adalimumab [USAN:INN:BAN]
RN: 331731-18-1
UNII: FYS6T7F842

Notes

  • A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
  • Anti-Tumor Necrosis Factor (TNF) human monoclonal antibody used to treat rheumatoid arthritis and other chronic inflammatory diseases.

Molecular Formula

  • Unspecified
 

Classification Codes

  • Anti-Inflammatory Agents
  • Antirheumatic Agents
  • Monoclonal Antibody
  • Treatment of Rheumatoid Arthritis and Other Chronic Inflammatory Diseases (Monoclonal Antibody)

Names and Synonyms

Name of Substance

  • Adalimumab [USAN:INN:BAN]

MeSH Heading

  • Adalimumab

Synonyms

  • ABP 501
  • Adalimumab
  • Adalimumab-adbm
  • Adalimumab-atto
  • Amjevita
  • Amjevita [adalimumab-atto]
  • Cyltezo
  • Cyltezo (Adalimumab-adbm)
  • D2E7
  • HSDB 7851
  • Humira
  • Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer. Molecular weight is approximately 148,000 daltons
  • LU200134
  • Trudexa
  • UNII-FYS6T7F842

Systematic Name

  • Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer

Registry Numbers

CAS Registry Number

  • 331731-18-1

FDA UNII

  • FYS6T7F842

System Generated Number

  • 0331731181